| Literature DB >> 24436848 |
William J Molinari1, Robert W Molinari1, Oner A Khera1, William L Gruhn1.
Abstract
Controversy exists as to the most effective management option for elderly patients with type II odontoid fractures. The purpose of this study is to evaluate outcomes associated with rigid cervical collar and posterior fusion surgery. Patients with ≥ 50% odontoid displacement were treated with posterior fusion surgery including C1-2 (PSF group, n = 25, average age = 80 years). Patients with < 50% odontoid displacement were treated with a rigid cervical collar for 12 weeks (collar group, n = 33, average age = 83 years). These inhomogeneous groups were followed for an average of 14 months. Fracture healing rates were higher in the operative group (28% versus 6%). Neck Disability Index scores were slightly lower in the nonoperative group (13 versus 18.3, p = 0.23). Analogue pain scores were also slightly lower in the nonoperative group (1.3 versus 1.9, p = 0.26). The mortality rate was 12.5% in the collar group and 20% in the operative group. Complications were higher in the operative group (24% versus 6%). Rates of type II odontoid facture healing and stability appear to be higher in geriatric patients treated with posterior fusion surgery. Fracture healing and stability did not correlate with improved outcomes with respect to levels of pain, function, and satisfaction. Mortality and complication rates are lower in those patients with lesser-displaced fractures who are treated with a cervical collar and early mobilization.Entities:
Keywords: fracture; geriatric; management; nonoperative; odontoid; operative
Year: 2013 PMID: 24436848 PMCID: PMC3854588 DOI: 10.1055/s-0033-1337122
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Patients and treatments
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gender | Age (y) | Treatment | Estimated blood loss (mL) | Surgical time (min) | Hospital Stay (d) | Complications | Follow-up (mo) | Comorbidities | |
| M | 89 | C1-2 PSF | 200 | 229 | 3 | 18 | 1. T cell Leukemia | 2. HTN | |
| M | 67 | C1-2 PSF | 300 | 151 | 4 | 24 | 1. HTN | ||
| M | 85 | C1-2 PSF | 300 | 120 | 4 | CSF leak | 36 | 1. CAD | 6. Anemia |
| M | 79 | C1-2 PSF | 300 | 227 | 6 | 48 | 1. GERD | 3. Depression | |
| M | 90 | C1-3 PSF | 300 | 108 | 10 | Perioperative death | 0.25 | 1. Venous insufficiency | 7. B12 deficiency |
| M | 81 | C1-3 PSF | 550 | 180 | 13 | Perioperative death | 0.25 | 1. Left eye blindness | 4. Dementia |
| M | 88 | C1-4 PSF | 700 | 163 | 8 | Deceased | 1 | 1. DM | 6. Anemia |
| F | 81 | C1-5 PSF | 100 | 123 | 20 | 48 | 1. HTN | 3. Bradycardia | |
| M | 85 | C1-3 PSF | 400 | 91 | 11 | Deceased | 2 | 1. DM | 5. HTN |
| F | 72 | C1-2 PSF | 500 | 85 | 4 | 40 | 1. Hepatitis C | ||
| M | 74 | C1-2 PSF | 350 | 119 | 5 | 2 | 1. HTN | 3. OA | |
| F | 78 | C1-2 PSF | 200 | 96 | 10 | 6 | 1. Breast CA | 3. Macular degeneration | |
| M | 79 | C1-2 PSF | 200 | 92 | 3 | Deceased | 2 | 1. Parkinsons | 4. BPH |
| F | 65 | C1-3 PSF | 50 | 92 | 4 | 24 | 1. Fibromyalgia | 4. Hypertension | |
| F | 82 | C1-3 PSF | 150 | 95 | 4 | 9 | 1. Dementia | 4. Hypercholesterolemia | |
| F | 87 | C1-3 PSF | 150 | 90 | 4 | 8 | 1. Osteoporosis | 3. Hyperlipidemia | |
| M | 73 | C1-3 PSF | 150 | 90 | 4 | 20 | 1. MI | 6. Anemia | |
| M | 81 | C1-T2 PSF | 700 | 110 | 4 | 9 | 1. Cataracts | ||
| F | 67 | C1-2 PSF | 300 | 86 | 11 | 6 | 1. HTN | 6. Chronic renal insufficiency | |
| F | 66 | C1-2 PSF | 100 | 83 | 2 | 6 | 1. HTN | 2. DM | |
| M | 65 | C1-2 PSF | 500 | 65 | 6 | 5 | 1. GERD | ||
| M | 86 | C1-2 PSF | 500 | 86 | 13 | Swallowing problem | 6 | 1. CAD | 6. Peripheral neuropathy |
| M | 86 | C1-2 PSF | 100 | 59 | 9 | 6 | 1. CVA | 4. GERD | |
| F | 79 | occ-c5 psf | 150 | 211 | 14 | Tracheotomy/ revision | 12 | 1. Parkinson's disease | 4. HTN |
| F | 83 | C1-2 PSF | 150 | 56 | 4 | Swallowing problem | 7 | 1. HTN | 6. Right shoulder rotator cuff arthropathy |
|
|
|
|
|
|
| ||||
|
| |||||||||
|
|
|
|
| Follow-up (mo) | |||||
| F | 86 | 1. HTN | 2. Osteoporosis | 44 | |||||
| F | 84 | 1. Gout | 2. B12 Deficiency | 6 | |||||
| M | 86 | None | 4 | ||||||
| F | 77 | 1. HTN | 3. Hyperlipidemia | 24 | |||||
| M | 71 | 1. Insulin dependent diabetes | 3. Hypercholesterolemia. | 34 | |||||
| F | 91 | 1. HTN | 3 | ||||||
| M | 81 | 1. HTN | 3. Chronic bronchiectasis | 6 | |||||
| F | 87 | 1. Demential | 6. Left bundle branch block | 3 | |||||
| F | 81 | 1. Hypothyroidism | 6. Depression | 48 | |||||
| M | 76 | 1. Atrial fibrillation | 2. Hypertension | 48 | |||||
| M | 80 | 1. Cirrhosis (Alcoholic) | 5. Abdominal aortic aneurysm | 4 | |||||
| M | 88 | 1. HLD | 6. Ovarian CA-s/p Oophorectomy | 2 | |||||
| M | 87 | 1. Hypertension. | 4. CAD- s/p 4 vessel CABG | 17 | |||||
| M | 80 | 1. Barrett's Esophagus | 6. Diabetic Retinopathy | 14 | |||||
| F | 78 | 1. Coronary artery disease | 4. Chronic UTI | 22 | |||||
| M | 89 | 1. HTN | 3. CAD- s/p stent | 16 | |||||
| F | 78 | 1. Megaloblastic Anemia | 3. Hyperlipidemia | 3 | |||||
| F | 84 | 1. Parkinson's disease | 4. Right carpal tunnel syndrome | 26 | |||||
| F | 71 | 1. HTN | 2. Depression |
| |||||
| M | 86 | 1. Atrial Fibrillation | 2. Hypertension | 21 | |||||
| F | 79 | 1. MRN match | 23 | ||||||
| F | 83 | 1. Coronary artery disease | 5. DVT | 41 | |||||
| M | 77 | 1. Diabetes Type 2 | 5. Hypertension-diagnosed at age 17 | 6 | |||||
| F | 99 | 1. HTN | 6 | ||||||
| M | 79 | None | 7 | ||||||
| M | 77 | None | 12 | ||||||
| F | 72 | 1. Prostate Cancer | 5. Osteoarthritis | 12 | |||||
| M | 98 | 1. Hx falls | 2. Hearing loss | 3 | |||||
| M | 83 | 1. HTN | 2. HLD | 6 | |||||
| M | 88 | 1. Hypertension | 3. Asthma | 6 | |||||
| M | 97 | Skin breakdown | 1. Atrial fibrillation | 4. BPH | 6 | ||||
| F | 81 | 1. CAD | 3.Dyslipidemia | 6 | |||||
| F | 91 | Skin breakdown | 1. Atrial Fibrillation | 4. DM | 6 | ||||
|
|
|
| |||||||
Abbreviations: AAA, abdominal aortic aneurysm; afib, atrial fibrillation; AVR, aortic valve regurgitation; BPH, benign prostate hyperplasia; Ca, cancer; CABG, coronary artery bypass graft; CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CSF, cerebrospinal fluid; CVA, cerebrovascular accident; DMT2, diabetes mellitus type II; DVT, deep venous thrombosis; GERD, gatroesophageal reflex disease; HLD, hyperlipidemia; HTN, hypertension; Hx, History; MI, myocardial ischemia; OA, osteoarthritis; PAC, premature atrial contractions; PSF, posterior spinal fusion; PUD, peptic ulcer disease; R, right; RA, rheumatoid arthritis; S/P, status post; SVT, supraventricular tachycardia; TURP, transurethral radical prosthetectomy; UTI, urinary tract infection; XRT, radiation therapy.
Fig. 1Midsagittal initial injury computed tomography images demonstrating (A) <50% odontoid displacement and (B) > 50% odontoid displacement.
Patient outcomes
| PSF group | Collar group | |
|---|---|---|
| Follow-up (mo), average (range) | 13.7 (0.25–48) | 13.9 (2–48) |
| Mortality | 20% (5/25) | 12.5% (4/33) |
| Complications | 24% (6/25) | 6% (2/33) |
| Fracture healing | 28% (7/25) | 6% (2/33) |
| Mobile nonunion | 0% | 67% (20/30) |
Abbreviation: PSF, posterior fusion surgery.
Fig. 2Barium swallow lateral image demonstrating esophageal narrowing in a patient treated with posterior fusion surgery who had prolonged swallowing difficulty greater than 3 months after surgery.
Fig. 3Flexion and extension lateral radiographs of a patient treated with posterior fusion surgery with stable odontoid nonunion.
Fig. 4Flexion and extension lateral radiographs of a collar patient with mobile odontoid nonunion.